Skip to main content

by Dr. C.H. Weaver M.D. 10/2023

Results of a retrospective analysis suggest individuals with myeloproliferative neoplasms may have an elevated risk of bone fractures Leukemia and Lymphoma.

Myeloproliferative neoplasms (MPN) are a related group of blood cancers. In these disorders, the bone marrow cells that produce blood cells develop and function abnormally. The three main types of MPN are polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). In addition to developing on its own, myelofibrosis may also develop as a result of ET or PMF.

MPN CancerConnect 490

Connect with Others in the CancerConnect MPN Community for Information and Support

PV and ET each result from the overproduction of certain types of blood cells. PMF involves scarring of the bone marrow and changes in blood cell production. MPN's are known to be associated with certain consequences such as itching and development of Budd Chiari or other clotting problems but an association with increased risk of fractures has not been previously reported.

Researchers from the Swedish Cancer Registry and the Swedish National Board of Health and Welfare evaluated the risks of hip and vertebral fracture in a Swedish cohort of adult patients with MPNs compared with the entire adult Swedish population during the period from 1995 to 2015.

Scroll to Continue

Recommended Articles

precision oncology

Genomics and Circulating Tumor DNA Monitoring Identify High Recurrence Risk Early-Stage Breast Cancer

More evidence of utility of tumor genomic testing and circulating tumor DNA (ctDNA) monitoring in early-stage breast cancer to reduce breast cancer recurrence

Image placeholder title

Blenrep (belantamab mafodotin) for Multiple Myeloma

Blenrep targets BCMA in myeloma; has concerns of ocular side effects and could be a new standard of care for Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Daratumumab Shows Promise in High-Risk Smoldering Multiple Myeloma

Progression to active multiple myeloma delayed with daratumumab monotherapy among high-risk patients with smoldering myeloma

The found that the incidences of hip and vertebral fractures were 5% and 1.3%, respectively in patients with MPN’s and this corresponded to a 20% to 30% increase for hip fractures and almost twice the risk of vertebral fractures compared with the general population with a relatively short follow up period.

The study authors did not offer an explanation for why individuals with a MPN might be at increased risk of bone fracture suggesting this must be addressed in future studies.

MPN Newsletter 490

MPN Newsletter

Connect With Others for Support and Information

CancerConnect was the first social network created for people with breast cancer. Founded by oncologists to support myeloma patients and their caregivers, over 40 million individuals have accessed CancerConnect programs since 1997. CancerConnect is used by leading cancer centers like Dana Farber, Roswell Park and The James at Ohio State to support their patients. Join the conversation, ask questions, share your experience, and learn how the best cancer centers are treating breast cancer from others. Share your experience, ask a question, or start a conversation by posting on CancerConnect.

Reference

Johansson P. Kristjansdottir HL, Johansson H, Jakir A, Mellstrom D, Lewerin C. Highly increased risk of fracture in patients with myeloproliferative neoplasm.Leuk Lymphoma. Published online September 10, 2020. doi:10.1080/10428194.2020.1817437